| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | China | 3 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Canada | 2 | |
| #6 | Japan | 2 | |
| #7 | Republic of Korea | 2 |
| # | Industry | |
|---|---|---|
| #1 | Measurement | |
| #2 | Pharmaceuticals | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Therapeutic chemical compounds | |
| #5 | Microorganisms | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Laing Lance Gavin | 19 |
| #2 | Sullivan Brian Francis | 12 |
| #3 | Rich Ben | 6 |
| #4 | Dandapat Abhijit | 6 |
| #5 | Brian Francis Sullivan | 2 |
| #6 | Lance Gavin Laing | 2 |
| #7 | Sullivan Brian | 1 |
| #8 | Sullivan Brian Franics | 1 |
| #9 | Laing Lance | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017070353A1 | Methods of preparing a primary cell sample | |
| CN107003300A | ERBB signal transduction pathway activity is measured to diagnose the method with treating cancer patient | |
| WO2015089380A2 | Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent | |
| WO2013188500A1 | Whole cell assays and methods |